These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18299717)

  • 1. Transcriptome Analysis for Cytoprotective Actions of Rebamipide against Indomethacin-Induced Gastric Mucosal Injury in Rats.
    Naito Y; Kuroda M; Mizushima K; Takagi T; Handa O; Kokura S; Yoshida N; Ichikawa H; Yoshikawa T
    J Clin Biochem Nutr; 2007 Nov; 41(3):202-10. PubMed ID: 18299717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rebamipide, a gastro-protective drug, inhibits indomethacin-induced apoptosis in cultured rat gastric mucosal cells: association with the inhibition of growth arrest and DNA damage-induced 45 alpha expression.
    Naito Y; Kajikawa H; Mizushima K; Shimozawa M; Kuroda M; Katada K; Takagi T; Handa O; Kokura S; Ichikawa H; Yoshida N; Matsui H; Yoshikawa T
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S104-12. PubMed ID: 16184411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebamipide reduces indomethacin-induced gastric injury in mice via down-regulation of ICAM-1 expression.
    Hiratsuka T; Futagami S; Shindo T; Hamamoto T; Ueki N; Suzuki K; Shinji Y; Kusunoki M; Shinoki K; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S84-9. PubMed ID: 16184426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rebamipide significantly inhibits indomethacin-induced mitochondrial damage, lipid peroxidation, and apoptosis in gastric epithelial RGM-1 cells.
    Nagano Y; Matsui H; Muramatsu M; Shimokawa O; Shibahara T; Yanaka A; Nakahara A; Matsuzaki Y; Tanaka N; Nakamura Y
    Dig Dis Sci; 2005 Oct; 50 Suppl 1():S76-83. PubMed ID: 16184425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity.
    Yamada S; Naito Y; Takagi T; Mizushima K; Horie R; Fukumoto K; Inoue K; Harusato A; Uchiyama K; Handa O; Yagi N; Ichikawa H; Yoshikawa T
    J Gastroenterol Hepatol; 2012 Dec; 27(12):1816-24. PubMed ID: 23020299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rebamipide protects small intestinal mucosal injuries caused by indomethacin by modulating intestinal microbiota and the gene expression in intestinal mucosa in a rat model.
    Kurata S; Nakashima T; Osaki T; Uematsu N; Shibamori M; Sakurai K; Kamiya S
    J Clin Biochem Nutr; 2015 Jan; 56(1):20-7. PubMed ID: 25834302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rebamipide, a mucoprotective drug, inhibits NSAIDs-induced gastric mucosal injury: possible involvement of the downregulation of 15-hydroxyprostaglandin dehydrogenase.
    Tanigawa T; Watanabe T; Ohkawa F; Nadatani Y; Otani K; Machida H; Okazaki H; Yamagami H; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    J Clin Biochem Nutr; 2011 Mar; 48(2):149-53. PubMed ID: 21373268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of growth arrest and DNA damage-inducible 45alpha expression confers resistance to sulindac and indomethacin-induced gastric mucosal injury.
    Chiou SK; Hodges A; Hoa N
    J Pharmacol Exp Ther; 2010 Sep; 334(3):693-702. PubMed ID: 20498252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rebamipide prevents indomethacin-induced gastric mucosal lesion formation by inhibiting activation of neutrophils in rats.
    Murakami K; Okajima K; Harada N; Isobe H; Okabe H
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):139S-142S. PubMed ID: 9753240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of Indomethacin-Induced Gastric Mucosal Injury in Helicobacter pylori-Negative Healthy Volunteers: A Comparison Study Rebamipide vs Famotidine.
    Naito Y; Iinuma S; Yagi N; Boku Y; Imamoto E; Takagi T; Handa O; Kokura S; Yoshikawa T
    J Clin Biochem Nutr; 2008 Jul; 43(1):34-40. PubMed ID: 18648657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rebamipide protects against indomethacin-induced gastric mucosal injury in healthy volunteers in a double-blind, placebo-controlled study.
    Naito Y; Yoshikawa T; Iinuma S; Yagi N; Matsuyama K; Boku Y; Fujii T; Yoshida N; Kondo M; Sasaki E
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):83S-89S. PubMed ID: 9753232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells.
    Hahm KB; Park IS; Kim YS; Kim JH; Cho SW; Lee SI; Youn JK
    Free Radic Biol Med; 1997; 22(4):711-6. PubMed ID: 9013134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats.
    Kleine A; Kluge S; Peskar BM
    Dig Dis Sci; 1993 Aug; 38(8):1441-9. PubMed ID: 8393757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of Irsogladine on monochloramine induced gastric mucosal lesions in rats:a comparative study with rebamipide.
    Yamamoto H; Umeda M; Mizoguchi H; Kato S; Takeuchi K
    World J Gastroenterol; 1999 Dec; 5(6):477-482. PubMed ID: 11819495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rebamipide attenuates indomethacin-induced gastric mucosal lesion formation by inhibiting activation of leukocytes in rats.
    Murakami K; Okajima K; Uchiba M; Harada N; Johno M; Okabe H; Takatsuki K
    Dig Dis Sci; 1997 Feb; 42(2):319-25. PubMed ID: 9052513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action?
    Tarnawski AS; Chai J; Pai R; Chiou SK
    Dig Dis Sci; 2004 Feb; 49(2):202-9. PubMed ID: 15104358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rebamipide inhibits indomethacin-induced small intestinal injury: possible involvement of intestinal microbiota modulation by upregulation of α-defensin 5.
    Tanigawa T; Watanabe T; Otani K; Nadatani Y; Ohkawa F; Sogawa M; Yamagami H; Shiba M; Watanabe K; Tominaga K; Fujiwara Y; Takeuchi K; Arakawa T
    Eur J Pharmacol; 2013 Mar; 704(1-3):64-9. PubMed ID: 23428631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of tumor necrosis factor-alpha and apoptosis in gastric mucosal injury by indomethacin: effect of omeprazole and ebrotidine.
    Slomiany BL; Piotrowski J; Slomiany A
    Scand J Gastroenterol; 1997 Jul; 32(7):638-42. PubMed ID: 9246701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent.
    Sun WH; Tsuji S; Tsujii M; Gunawan ES; Kawai N; Kimura A; Kakiuchi Y; Yasumaru M; Iijima H; Okuda Y; Sasaki Y; Hori M; Kawano S
    J Pharmacol Exp Ther; 2000 Nov; 295(2):447-52. PubMed ID: 11046075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
    Yoshida N; Ishikawa T; Ichiishi E; Yoshida Y; Hanashiro K; Kuchide M; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Yamamura Y; Okanoue T; Yoshikawa T
    Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():63-75. PubMed ID: 12925142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.